As of 16 Sept 2024, Glenmark Pharmaceuticals total assets is $2.31B, an increase of 13.40% to 2022. This figure includes all the resources and properties owned by Glenmark Pharmaceuticals, reflecting its financial standing at that time.
Year | Total Assets | Change |
---|---|---|
2023 | $2.31B | 13.40% |
2022 | $2.04B | 9.48% |
2021 | $1.86B | 6.26% |
2020 | $1.75B | 7.35% |
2019 | $1.63B | - |